Abstract. The predominant risk factor of metabolic syndrome is intra-abdominal fat accumulation, which is determined by waist circumference, waist-hip ratio measurements and visceral fat area (VFA); the latter can be accurately measured by performing computed tomography (CT). In addition to environmental factors, genetic factors play an important role in obesity and fat distribution. New genetic loci associated with body mass index (BMI) and adiposity have been identified by genome-wide association studies (GWASs). This study utilized CT to investigate whether single nucleotide polymorphisms (SNPs) that confer susceptibility to higher BMI are associated with VFA, subcutaneous fat area (SFA), and the ratio of VFA to SFA (V/S ratio). We measured the VFA and SFA of 1424 obese Japanese subjects (BMI ≥ 25 kg/m 2 , 635 men and 789 women) who were genotyped for 13 single nucleotide polymorphisms (SNPs) reported by recent GWASs, namely, TNNI3K rs1514175, PTBP2 rs1555543, ADCY3 rs713586, IRS1 rs2943650, POC5 rs2112347, NUDT3 rs206936, LINGO2 rs10968576, STK33 rs4929949, MTIF3 rs4771122, SPRY2 rs534870, MAP2K5 rs2241423, QPCTL rs2287019, and ZC3H4 rs3810291. The G-allele of NUDT3 rs206936 was significantly associated with increased BMI (P = 5.3 × 10 -5 ) and SFA (P = 0.00039) in the obese Japanese women. After adjustment with BMI, the association between rs206936 and SFA was not observed. This significant association was not observed in the men. The other SNPs analyzed were not significantly associated with BMI, VFA, SFA, or V/S ratio. Our results suggest that NUDT3 rs206936 is associated with BMI in Japanese women.
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Materials & Methods

Subjects
We enlisted 1424 Japanese subjects who had visited 9 outpatient clinics during 2002 to 2011, to undergo treatment for obesity (BMI ≥ 25 kg/m 2 ) with or without metabolic abnormalities such as hypertension, dyslipidemia, and type 2 diabetes. Obesity (BMI ≥25 kg/m 2 ) was diagnosed according to the Japanese obesity criteria [23] . Patients with secondary obesity and obesity-related hereditary disorders were excluded from this study. The patients agreed to undergo CT testing (in the supine position) to determine the VFA, and SFA values at the umbilical level (L4-L5), as previously reported [24] . The values of VFA, and SFA were calculated using the FatScan software program (N2system, Osaka, Japan) [24] . Clinical data were recorded at the first visit to the hospital, and the clinical characteristics of the subjects are summarized in Table 1 . Written informed consent was obtained from each subject, and the protocol was approved by the ethics committee of each institution and Kyoto University.
DNA extraction and SNP genotyping
Genomic DNA was extracted from the blood samples collected from each subject using the Genomix kit (Talent Srl, Trieste, Italy). We selected 13 SNPs that were recently identified as loci associated with BMI or adiposity by meta-analysis [21, 22] , and constructed Invader probes (Third Wave Technologies, Madison, WI, USA). The following 13 SNPs were genotyped and used for analysis: rs1514175 in the TNNI3 interacting kinase (TNNI3K) gene; rs1555543 in the polypyrimidine tract binding protein 2 (PTBP2) gene; rs713586 in the adenylate cyclase 3 (ADCY3) gene; rs2943650 in the IRS1 gene; rs2112347 in the POC5 centriolar protein homolog (POC5) gene; rs206936 in the nudix (nucleoside diphosphate linked moiety X)-type motif 3 (NUDT3) gene; rs10968576 in the leucine rich repeat and Ig domain containing 2 (LINGO2) gene; rs4929949 in the serine/threonine kinase 33 (STK33) gene; rs4771122 in the mitochondrial translational initiation factor 3 (MTIF3) gene; rs534870 in the SPRY2 gene; rs2241423 in the mitogen-activated protein drome. Specifically, abnormal fat distribution is more closely related to metabolic syndrome than increased absolute fat volume [1] [2] . The accumulation of intraabdominal visceral fat plays a major role in metabolic syndrome, as the accumulated visceral adipose tissue leads to alterations in the plasma levels of adipocytokines, which thereby result in the development of dyslipidemia, hypertension, and insulin resistance [2, 3] . Numerous evidences support the fact that body fat distribution is influenced by genetic loci [4] [5] [6] [7] . Fat distribution is determined on the basis of waist circumference, waist-hip ratio, biological impedance, or visceral fat area (VFA) measured using computed tomography (CT) [1, 8, 9] . Recent progress using genomewide association studies (GWASs) has identified 17 loci linked to waist circumference or waist-hip ratio [10] [11] [12] . Very recently, 3 genetic loci associated with VFA and subcutaneous fat area (SFA) determined using CT were identified by GWASs [13] . We have examined the reported loci, and determined that single nucleotide polymorphisms (SNPs) in the fat mass-and obesity-associated (FTO) gene were significantly linked to SFA and that lysophospholipase-like protein 1 (LYPLAL1) rs4846567 is associated with the ratio of VFA to SFA (V/S ratio) in the Japanese population [14] [15] [16] .
Recent progress in GWASs has increased the number of known genetic susceptibility loci for obesity [17] [18] [19] . We have reported that among SNPs that increase susceptibility to obesity, rs7498665 in the SH2B adaptor protein 1 (SH2B1) gene is specifically associated with VFA [20] . Recent report has identified 18 novel loci that influence susceptibility to obesity [21] , and genetic variation in the insulin receptor substrate 1 (IRS1) and sprouty homolog 2 (SPRY2) genes have been associated with adiposity [22] . Among 20 SNPs, 6 SNPs are monomorphic in the Japanese population: rs2890652 in the low density lipoprotein receptor-related protein 1B (LRP1B) gene; rs887912 in the FLJ30838 gene; rs13078807 in the cell adhesion molecule 2 (CADM2) gene; rs13107325 in the solute carrier family 39 (zinc transporter), member 8 (SLC39A8) gene; rs11847697 in the protein kinase D1 (PRKD1) gene; and rs12444979 in the G protein-coupled receptor, family C, group 5, member B (GPRC5B) gene (from HapMap database). rs4836133 in the zinc finger protein 608 (ZNF608) gene is tri-allelic in the Japanese population.
It is not clear whether novel body mass index (BMI) or adiposity-associated SNPs affect the accumulation
Results
The clinical characteristics and genotypes of the subjects are shown in Tables 1 and Supplementary  Table 2 , respectively. All the SNPs were in HardyWeinberg equilibrium, except rs4929949 (P = 0.040) and rs3810291 (P = 0.026) in men, and rs2943650 in women (P = 0.040). The risk allele frequencies did not diverge from those reported in the HapMap database. We confirmed that 6 SNPs were monomorphic in the Japanese population: rs2890652 in the LRP1B gene, rs887912 in the FLJ30838 gene, rs13078807 in the CADM2 gene, rs13107325 in the SLC39A8 gene, rs11847697 in the PRKD1 gene, and rs12444979 in the GPRC5B gene. We found that rs4836133 in the ZNF608 gene was tri-allelic in the population (A, 43.9%; C, 33.4%; G, 22.7%).
The BMI, VFA, and SFA are known to be affected by gender [27] , and therefore, we independently compared BMI-associated SNPs with the fat distribution parameters (BMI, VFA, and SFA) in men and women. Multiple linear regression analyses of the anthropometric parameters with respect to the 13 analyzed SNPs are shown in Tables 2, 3 , 4, and 5. The G-allele of rs206936 was significantly associated with BMI in women (P = 5.3 × 10 -5 ) but not in men (P = 0.19). SNP rs1555543 in the PTBP2 gene was weakly associated with BMI in men (P = 0.017, Table 2 ): however, its association was not significant. Two SNPs, namely, rs2112347 in the POC5 gene (P = 0.032) and rs206936 in the kinase kinase 5 (MAP2K5) gene; rs2287019 in the glutaminyl-peptide cyclotransferase-like (QPCTL) gene; and rs3810291 in the zinc finger CCCH-type containing 4 (ZC3H4) gene. The SNPs were genotyped using Invader assays, as previously described [25] . The success rate of these assays was >99.0%.
Statistical analysis
For the additive model, we characterized the genotypes as 0, 1, or 2 depending on the number of copies of the risk alleles. For the dominant model, homozygosity and heterozygosity with the risk allele were coded as 1 and the other was coded as 0. For the recessive model, homozygosity with the risk allele was coded as 1 and others were coded as 0. Risk alleles refer to the BMI-associated alleles previously identified [21, 22] . Multiple linear regression analyses were performed to test the independent effect per allele of each SNP on BMI, VFA, SFA, and V/S ratio, by accounting for the effects of the other variables (i.e., age, sex, and BMI). The BMI, VFA, SFA, and V/S ratio values were logarithmically transformed before performing the multiple linear regression analysis. Hardy-Weinberg equilibrium was assessed using the χ 2 -test [26] . The statistical analysis was performed using R software (http://www.r-project.org/). P-values were assessed by using Bonferroni correction, and a P-value of <0.00096 (0.05/13 SNPs/4 traits) was considered statistically significant. , n = 585 in men and n = 727 in women. Data are expressed as means ± SD. Allele1, allele 2, and the risk allele of each SNP are indicated in Supplementary Table 1 . The effect size and P-values are derived from a linear regression analysis. V/S ratio was adjusted for age, and log-transformed for the analysis. 11, allele1/allele1; 12, allele1/allele2; 22, allele2/allele2.
women, was not associated with any metabolic disorders (Supplementary Table 2 ), as reported in previous studies [21, 30] .
Discussion
We showed that rs206936 was significantly associated with BMI in Japanese women. Similar observation was also reported in Korean population where rs206936 is also associated with BMI [31] . Thus, rs206936 is likely to be associated with BMI in Asian population. However, we were unable to replicate the association of BMI with any other SNPs. We conducted the power analysis of linear regression (additive model) with a significance level of 0.05, using age and gender as explanatory parameters. The estimated effect sizes per allele (regression coefficients) for logarithmically transformed BMI, allele frequency of rs206936 was used. The power of our statistical test was calculated on the basis of these estimated effect sizes and by performing 10,000 simulations. The power for BMI was estimated to be 0.57 in total subjects, 0.26 in men, and 0.98 in women. Therefore, the failure to replicate the association is likely due to a lack of power, especially in men. This result may be also due to the ethnic differences in linkage disequilibrium (LD) patterns, ethnic-specific association, NUDT3 gene (P = 0.018), were weakly, but not significantly, associated with VFA in women (Table 3) . After adjustment with BMI, no associations were observed. rs2943650 in the IRS1 gene was associated with reduced VFA, after adjustment of BMI in women (P = 0.041), although it is not significant. SNP rs206936 in the NUDT3 gene was significantly associated with the SFA in women (P = 0.00039), but not in men, which is similar to the results obtained with respect to BMI and its association was disappeared after the adjustment of BMI (Table 4) . SNP rs4771122 in the MTIF3 gene was weakly (not significantly), associated with the SFA after adjustment in men (P = 0.027). rs3810291 in the ZC3H4 gene was weakly (not significantly) associated with SFA after adjustment with BMI in women (P = 0.0083). No SNP was associated with V/S ratio (Table  5) . We analyzed SNPs with P-value less than 0.05 in recessive and dominant model. Recessive model fitted better for rs2943650 in the IRS1 and dominant model for rs2112347 in the POC5 gene (Table 6) . Additive model fitted better for other SNPs.
Obesity, especially visceral fat obesity, is a major risk factor for metabolic disorders [9, 28, 29] . We examined the effect of 12 SNPs on metabolic traits. The G-allele of rs206936 in the NUDT3 gene, which was significantly associated with BMI and SFA in Data are expressed as the means ± SD. Allele1, allele 2, and the risk allele of each SNP are indicated in Supplementary Table 1 . The effect size and P-values are derived from a linear regression analysis. Number in bold indicates P <0.05. 11, allele1/allele1; 12, allele1/allele2; 22, allele2/allele2. and gene/environmental interactions. Interestingly, 6 SNPs were monomorphic and SNP rs4836133 was triallelic in the Japanese population. We found that rs206936 in the NUDT3 gene was strongly associated with BMI and SFA only in women. rs206936 was weakly associated with increased VFA, but not with V/S ratio in women. Associations between rs206936, and SFA and VFA disappeared after adjustment with BMI, indicating that increased SFA and VFA are driven by increased BMI. A previously reported study did not show any association between rs206936 and VFA, SFA, and V/S ratio in both women and men [13] . The power was estimated to be 0.10 in men and 0.63 in women for VFA, 0.36 in men and 0.95 in women for SFA, and 0.19 in men and 0.05 in women for V/S ratio. Therefore, further studies comprising more subjects are required to investigate the association between rs206936 and SFA; however, rs206936 in the NUDT3 gene is a good candidate for involvement in the accumulation of subcutaneous fat that leads to increased BMI. SNP rs2112347 in the POC5 gene (P = 0.032) and rs206936 in the NUDT3 gene (P = 0.018), were not significantly, but weakly, associated with VFA in women. A very recent report indicated that rs2112347 is weakly associated with visceral fat tissue in women (P = 0.002) [13] , and thus, rs2112347 may be associated with visceral fat accumulation. T-allele of rs2943650 in the IRS1 gene is associated with decreased adiposity, especially reduced subcutaneous fat and the ratio of increased visceral fat to subcutaneous fat [22] . We observed that T-allele of rs2943650 was weakly associated with reduced VFA even after adjustment with BMI (P = 0.041). Thus, rs2943650 may also be associated with fat distribution in the Japanese.
Sexual dimorphism in fat distribution has been acknowledged long ago [27] . Under the sexual dimorphism in fat distribution, there are sex-specific genetic effects and genetic variance reported to be higher in women for the waist, hip and thigh circumference, and waist to hip ratio [32] . In our study, we observed the strong association of rs206936 in the NUDT3 gene with SFA in women only. Thus, rs206936 in the NUDT3 may be one of the sex-specific genetic variances. The SNPs in the FTO gene and rs7498665 in the SH2B1 gene are associated with fat distribution, in men and women [14, 15, 20] . We have recently reported that SNPs in the CYP17A1 and NT5C2 genes were significantly associated with both reduced VFA and SFA in women, but not in men [33] . In addition, LYPLAL1 rs4846567 has a stronger effect on the V/S ratio in women than in men [13, 16] . Therefore, some of the genetic variants may contribute the sex-specific genetic variances in fat distribution, possibly through sex steroids on transcription. Our studies [16, 33] and previous GWASs [10, 12, 13, 22] have highlighted the importance of understanding the underlying molecular mechanisms in sex differences in the regulation of body fat distribution.
The NUDT3 rs206936 genotype did not show any association with metabolic disorders. This result was consistent with that of a previous report [30] . Visceral fat accumulation is more strongly linked to metabolic disorders than subcutaneous fat accumulation [1, 2, 28, 29] . The NUDT3 rs206936 genotype showed strong association with SFA, and weak association with VFA and no association with V/S ratio.
NUDT3 is expressed in various tissues and has phosphatase activity directed against inorganic polyphosphates: diphosphoinositol pentakisphosphate and bis-diphosphoinositol tetrakisphosphate [34, 35] . Diphosphoinositol pentakisphosphate is reported to inhibit Akt signaling, which consists of a part of insulin singling system [36] . SNP rs206936 is situated in the intron 2 of the NUDT3 gene and rs206936 may increase the NUDT3 transcripts in the liver [21] . According to the HapMap database, rs206942 is in LD with rs206936 (r 2 > 0.90) and exists in the 3′-untranslated region of the NUDT3 gene. rs206942 would influence the mRNA stabilization. Five SNPs (rs12662905, rs464553, rs3798560, rs206919 and rs6912971) in LD with rs206936 (r 2 > 0.90) exists in the 1st intron, suggesting these SNPs would alter the transcription level of NUDT3 gene. The NUDT3 may be high in the subjects with risk allele and diphosphoinositol pentakisphosphate decreased catalyzed by NUDT3, resulting in the increased sensitivity of insulin signaling. Insulin stimulates lipid storage in adipose tissue, leading to obesity. Although the precise roles of NUDT3 and inorganic polyphosphates are unclear, NUDT3 may be involved in glucose and lipid metabolism through the regulation of intra-cellular signaling systems, thereby leading to the accumulation of fat.
In summary, we showed that NUDT3 rs206936 is significantly associated with increased BMI and SFA in Japanese women. Our results suggest that the region containing the identified SNP in the NUTD3 gene is specifically involved in increasing the relative amount of subcutaneous fat mass in women.
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